Lucence Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Lucence is a midsize biotechnology company focused on precision health, applying AI-powered analysis to liquid biopsy samples to detect cancers earlier when outcomes are more favorable. Headquartered in Palo Alto, California, and Singapore, the firm operates two CLIA-certified laboratories in the United States and Singapore to deliver personalized cancer care services. Its work aims to provide clinicians with earlier, more actionable information to guide patient management. Its customers are healthcare providers seeking improved cancer detection and monitoring options, supported by partnerships with national cancer centers and research institutions. In March 2026, Lucence announced UNITED 2.0, a collaboration with A*STAR Diagnostics Development Hub and the National Cancer Centre Singapore to advance next-generation cancer profiling through AI-driven research.